NCT06057220View on ClinicalTrials.gov

IMaC - Immune Pathways in Oesophagogastric Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Oesophagogastric Cancer
Interventions
OTHER

No intervention sample collection only

No intervention

Trial Locations (3)

GU27WG

Royal Surrey County Hospital, Guildford

SW17 0QT

St Georges University Hospital, London

SW36JJ

The Royal Marsden NHS Foundation Trust, London

All Listed Sponsors
collaborator

Imperial College London

OTHER

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT06057220 - IMaC - Immune Pathways in Oesophagogastric Cancer | Biotech Hunter | Biotech Hunter